The lack of sensitivity of methicillin resistant Staphylococcus aureus (MRSA) toward teicoplanin
Abstract
A total of 60 methicillin resistant Staphylococcus aureus (MRSA) strains clinical samples in children were collected from cellulitis, abscess, and wound samples in Al-Hilla, and Babylon teaching hospital was identified to species level and antibiotic susceptibility testing with a VITEK-2 system. In the present study, 24 (40%) of MRSA isolates were community- acquired methicillin resistant Staphylococcus aureus (CA-MRSA), and 36 (60%) were hospitalized-acquired methicillin resistant Staphylococcus aureus (HA-MRSA). The results showed that 35 of female, and 25 of male of MRSA isolates, and these isolates were taken from 7 of infants aged less than 6 months, and 53 children aged between 6 months and 4 years of MRSA isolates. In the present study, antimicrobial susceptibility testing with the VITEK 2 system gave resistant to 10 and sensitive to 6 antibiotics to all bacterial isolates, but only 3(5%) of bacterial isolates were resistant to teicoplanin.
Downloads
References
- Moran, G.J.; Krishnadasan, A.; Gorwitz, R.J.; Fosheim, G.E.; McDougal, L.K.; Carey, R.B. and Talan D.A. (2006). Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355: 666-74.
- Anderson, M.E.; Lefebvre, S.L.; Rankin, S.C.; Aceto, H.; Morley, P.S.; Caron, J.P.; Welsh, R.D.; Holbrook, T.C.; Moore, B.; Taylor, D.R. and Weese J.S. (2009). Retrospective multicentre study of methicillin resistant Staphylococcus aureus infections in115 horses. Equine Vet. J. 41(4):401-5.
- Aspiroz, C.; Lozano, C.; Vindel, A.; Lasarte, J.J.; Zarazaga, M. and Torres C. (2010). Skin lesion caused by ST398 and ST1 MRSA, Spain. Emerg. Infect. Dis. 16(1):157-9.
- Bagcigil, F.A.; Moodley, A.; Baptiste, K.E.; Jensen, V.F. and Guardabassi L. (2007). Occurrence, species distribution, antimicrobial resistance and clonality of methicillin- and erythromycin-resistant staphylococci in the nasal cavity of domestic animals. Vet. Microbiol. 121(3-4):307-15.
- Weese, J.S.; Rousseau, J.; Willey, B.M.; Archambault, M.; McGeer, A. and Low D.E. (2006). MRSA in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J. Vet. Intern. Med. 20 (1):182-6.
- Blaine, K.P.; Tuohy, M.J.; Wilson, D.; Procop, G.W.; Tisch, D.J.; Shrestha, N.K. and Hall G.S. (2010). Progression to bacteremia in critical care patients colonized with methicillin-resistant S. aureus expressing Panton-Valentine leukocidin. Diagn. Microbiol. Infect. Dis. 68 (1) : 28-33.
- Redpath, M.B.; Foster, T.J. and Bailey C.J. (1991). The role of serine protease active site in the mode of action of epidermolytic toxin of S. aureus. FEMS Microbiol. Lett. 81:151±6.
- Iyer, S. and Jones D. H. (2003). Community-acquired methicillin-resistant S. aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak. J. of the American Academy of Dermatology. 50 (6): 854–858.
- Melish M.E. (1982). Staphylococci, streptococci and the skin: review of impetigo and staphylococcal scalded skin syndrome. Semin. Dermatol. 1:101±9.
- Kaplan, S. L.; Hulten, K. G.; Gonzalez, B. E.; Hammerman, W. A.; Lamberth, L.; Versalovic, J. and Mason E. O. (2005). Three-Year Surveillance of Community-Acquired S. aureus Infections in Children. Clin. Infect. Dis. 40 (12): 1785-1791.
- Ang, J.Y.; Ezike, E. and Asmar B. (2004). Antibacterial resistance. Indian. J. pediatr. 71 (3): 229-239.
- Weigelt J.A. (2007). MRSA Informa Healthcare. The role of nasal carriage in Staphylococcus aureus infections. Lancet. Infect. Dis. 5: 751-762.
- Forbes, B.A.; Daniel, F.S. and Alice S.W. (2007). Bailey and Scott diagnostic microbiology. 12th ed., Mosby Elsevier company, USA.
- Lindqvist, M.; Isaksson, B.; Samuelsson, A.; Nilsson, LE. and Hallgren A. (2009). A clonal outbreak of methicillin-susceptible Staphylococcus aureus with concomitant resistance to erythromycin, clindamycin and tobramycin in a Swedish county. Scand J. Infect. Dis., 41 (5): 324-33.
- Mitscher L.A .(2004). Bacterial topoisomerase inhibitors: Quinolone and pyridone antibacterial agents. Chem. Rev., 105 (2): 559-592.
- Rubin, B.K. and Tamaoki J. (2005). Antibiotics as anti-inflammatory and immunomodulatory agents. Birkhauser Verlag, PP:6.
- Lim, HS.; Lee, H.; Roh, KH.; Yum, JH.; Yong, D.; Lee, K. and Chong Y. (2006). Prevalence of inducible clindamycin resistance in staphylococcal isolates at Korean tertiary care hospital. Yonsei J. Med., 47: 480–4.
- Ge, M.; Chen, Z.; Onishi, H. R.; Kohler J.; Silver, L. L.; Kerns, R. S. Fukuzawa,Thompson, C. and Kahne D. (1999). Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding d-Ala-d-Ala. Science, 284: 507-511.
- Brooks, G.F.; Carroll, K.C.; Butel, J.S. and Morse S.A. (2007). Jawetz, melnik and aldelbergs medical microbiology. 24 rd ed. Lange Medical Books, McGraw-Hill.
- Fluit1, A. C.; Wielders, C. L. C.; Verhoef1, J. and Schmitz F.-J. (2001). Epidemiology and Susceptibility of 3,051 S.aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study. J. Clin. Microbiol., 39 (10): 3727- 32.
- Drew, RH. (2007). Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy, 27: 227-49.
- Chen, AE.; Goldstein, M.; Carroll, K.; Song, X.; Perl, TM. and Siberry GK. (2006). Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital. Pediatr. Emerg. Care. , 22: 717-23.
- Randrianirina, F.; Soares, JL.; Ratsima, E.; Carod, J.-F.; Combe, P.; Grosjean, P.; Richard, V. and Talarmin A. (2007). In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar. Ann. Clin. Microbiol. Antimicrob., 6:5.
Copyright (c) 2015 Acta Medica Scientia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
A) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
B) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
C) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
